Drug Type Small molecule drug |
Synonyms WAY-126299A |
Target |
Action inhibitors, antagonists |
Mechanism 5-LOX inhibitors(Arachidonate 5-lipoxygenase inhibitors), CysLT antagonists(Cysteinyl leukotriene receptor antagonists), CysLT1 antagonists(Cysteinyl leukotriene receptor 1 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC22H20N2NaO3S |
InChIKeyXAVDHTGQOSVEIA-UQKRIMTDSA-N |
CAS Registry169626-43-1 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Inflammation | Preclinical | United States | 01 Aug 1995 | |
| Asthma | Discovery | United States | - |





